Break it Down: Tryptamine Therapeutics’ rad results for Fibromyalgia patients

stockhead.com.au - 12/Sep 03:21

Stockhead TV's Sarah Hughan brings you today's Break it Down, detailing the new prospective copper acquisition from Belararox (ASX:BRX). ...

stockhead.com.au - 09/Sep 03:55

In this episode of Break it Down, host Fraser Palamara unpacks the acquisition action taking place around lithium opportunities in ...

stockhead.com.au - 09/Sep 03:55

In this episode of Break it Down, host Fraser Palamara unpacks the acquisition action taking place around lithium opportunities in ...

stockhead.com.au - 10/Sep 01:58

In this episode of Break it Down, host Fraser Palamara examines the new project in British Columbia Equinox Resources (ASX:EQN) ...

stockhead.com.au - 10/Sep 01:58

In this episode of Break it Down, host Fraser Palamara examines the new project in British Columbia Equinox Resources (ASX:EQN) ...

stockhead.com.au - 03/Sep 02:08

In this episode of Break it Down, host Fraser Palamara charts the major copper intersections from American West Metals (ASX:AW1) ...

stockhead.com.au - 06/Sep 01:55

In this episode of Break it Down, Fraser Palamara explains why the Canadian market is so important for Aussie pharmaceutical ...

stockhead.com.au - 06/Sep 01:55

In this episode of Break it Down, Fraser Palamara explains why the Canadian market is so important for Aussie pharmaceutical ...

stockhead.com.au - 15/Sep 23:12

Stockhead’s Sarah Hughan sits down with TG Metals' CEO Dave Selfe to discuss the recent high-grade lithium hits in pegmatites ...

stockhead.com.au - 09/Sep 03:07

In this episode, Fraser Palamara dissects the latest announcement from biopharmaceutical developer Neurotech International (ASX:NTI). ...

Rubriques :